Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$18.02 USD
+0.28 (1.58%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $18.04 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Sabra Healthcare REIT, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 47 | 54 | 116 | 66 | 49 |
Receivables | 421 | 411 | 399 | 103 | 107 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 467 | 465 | 515 | 168 | 157 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 4,754 | 5,094 | 5,260 | 5,574 | 5,661 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 31 | 40 | 54 | 83 | 102 |
Deposits & Other Assets | 134 | 148 | 138 | 161 | 150 |
Total Assets | 5,386 | 5,748 | 5,967 | 5,986 | 6,069 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 137 | 142 | 143 | 146 | 109 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 137 | 142 | 143 | 146 | 109 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,414 | 2,507 | 2,394 | 2,372 | 2,402 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,584 | 2,691 | 2,587 | 2,576 | 2,581 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 4,495 | 4,487 | 4,482 | 4,163 | 4,072 |
Retained Earnings | -1,718 | -1,452 | -1,095 | -716 | -573 |
Other Equity | 24 | 19 | -10 | -40 | -12 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 2,803 | 3,056 | 3,380 | 3,409 | 3,488 |
Total Liabilities & Shareholder's Equity | 5,386 | 5,748 | 5,967 | 5,986 | 6,069 |
Total Common Equity | 2,803 | 3,056 | 3,380 | 3,409 | 3,488 |
Shares Outstanding | 231.20 | 230.90 | 228.60 | 206.90 | 202.30 |
Book Value Per Share | 12.12 | 13.24 | 14.78 | 16.48 | 17.24 |
Fiscal Year End for Sabra Healthcare REIT, Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 42 | 66 | 47 | 39 |
Receivables | NA | 439 | 422 | 421 | 418 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 481 | 488 | 467 | 457 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 4,696 | 4,709 | 4,754 | 4,739 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 28 | 28 | 31 | 33 |
Deposits & Other Assets | NA | 146 | 148 | 134 | 152 |
Total Assets | NA | 5,351 | 5,374 | 5,386 | 5,381 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 113 | 113 | 137 | 128 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 113 | 113 | 137 | 128 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2,447 | 2,463 | 2,414 | 2,349 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 2,589 | 2,607 | 2,584 | 2,512 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 2 | 2 | 2 | 2 |
Capital Surplus | NA | 4,537 | 4,496 | 4,495 | 4,492 |
Retained Earnings | NA | -1,808 | -1,762 | -1,718 | -1,665 |
Other Equity | NA | 31 | 31 | 24 | 40 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 2,762 | 2,767 | 2,803 | 2,869 |
Total Liabilities & Shareholder's Equity | NA | 5,351 | 5,374 | 5,386 | 5,381 |
Total Common Equity | 0 | 2,762 | 2,767 | 2,803 | 2,869 |
Shares Outstanding | 234.20 | 231.50 | 231.50 | 231.20 | 231.20 |
Book Value Per Share | 0.00 | 11.93 | 11.95 | 12.12 | 12.41 |